Market Cap 376.11M
Revenue (ttm) 160.01M
Net Income (ttm) -546.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -341.47%
Debt to Equity Ratio 0.00
Volume 7,268,554
Avg Vol 6,420,398
Day's Range N/A - N/A
Shares Out 310.83M
Stochastic %K 29%
Beta 2.31
Analysts Sell
Price Target $2.32

Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonuclea...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 521 8000
Fax: 650 618 2699
Address:
1305 O’Brien Drive, Menlo Park, United States
dopeles
dopeles Aug. 19 at 5:26 PM
$MRNA + $PACB I’m calling it
0 · Reply
dopeles
dopeles Aug. 19 at 5:21 PM
$PACB ‼️🚨 ….Moderna will acquire PACB …bcus nothig else makes sense
0 · Reply
PraRed
PraRed Aug. 19 at 5:12 PM
$MRNA $PACB 👀🫣👀🫣✅
0 · Reply
Multi_Millions
Multi_Millions Aug. 19 at 4:13 PM
0 · Reply
FinanceCorp
FinanceCorp Aug. 19 at 3:50 PM
0 · Reply
MingLin
MingLin Aug. 19 at 3:47 PM
$PACB more meat next short reverse split land 👍🏽🇨🇳
1 · Reply
egcgfiend
egcgfiend Aug. 19 at 2:46 PM
$PACB 100x coming
1 · Reply
lilin_
lilin_ Aug. 19 at 2:43 PM
$PACB 誰在昨天買了更多
1 · Reply
severfire
severfire Aug. 19 at 2:24 PM
$MRNA Worth knowing it is good to do genetic testing during genetic curation. I guess $PACB would be best fit here!
0 · Reply
severfire
severfire Aug. 19 at 2:04 PM
$PACB from AI: DNA tests are strongly recommended and often required during genetic curations. They provide the core molecular data needed to interpret gene-disease validity, classify variant pathogenicity, and confirm clinical findings in genomic databases. Role of DNA Tests in Curations Variant Discovery: Identifies specific changes in the genetic code of affected individuals. Segregation Analysis: Tests family members to see if the DNA change tracks with the disease. Functional Correlation: Links specific genotypes to observed patient phenotypes.Database Populating: Feeds real-world genomic data into expert panels like ClinGen.
0 · Reply
Latest News on PACB
PacBio CEO Christian Henry steps down, Mark Van Oene succeeds

2026-08-05T23:35:34.000Z - 13 days ago

PacBio CEO Christian Henry steps down, Mark Van Oene succeeds


PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M

2026-08-05T21:31:02.000Z - 13 days ago

PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M


Pacific Biosciences of California Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Pacific Biosciences of California Slides: Q2 2026


Pacific Biosciences of California Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Pacific Biosciences of California Earnings release: Q2 2026


Pacific Biosciences of California Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Pacific Biosciences of California Quarterly report: Q2 2026


PacBio Announces Second Quarter 2026 Financial Results

Aug 5, 2026, 4:05 PM EDT - 13 days ago

PacBio Announces Second Quarter 2026 Financial Results


Pacific Biosciences of California Transcript: Status update

Jun 18, 2026, 11:00 AM EDT - 2 months ago

Pacific Biosciences of California Transcript: Status update


Pacific Biosciences of California Transcript: AGM 2026

Jun 3, 2026, 12:00 PM EDT - 2 months ago

Pacific Biosciences of California Transcript: AGM 2026


PacBio announces SPRQ-Nx chemistry now shipping worldwide

2026-05-26T13:35:56.000Z - 3 months ago

PacBio announces SPRQ-Nx chemistry now shipping worldwide


Pacific Biosciences of California Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

Pacific Biosciences of California Proxy statement: Proxy filing


PacBio price target raised to $1.50 from $1 at Barclays

2026-05-11T10:14:51.000Z - 3 months ago

PacBio price target raised to $1.50 from $1 at Barclays


PacBio sees FY26 revenue $165M-$175M, consensus $174.42M

2026-05-07T22:16:25.000Z - 3 months ago

PacBio sees FY26 revenue $165M-$175M, consensus $174.42M


Pacific Biosciences of California Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Pacific Biosciences of California Slides: Q1 2026


Pacific Biosciences of California Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Pacific Biosciences of California Earnings release: Q1 2026


Pacific Biosciences of California Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Pacific Biosciences of California Quarterly report: Q1 2026


PacBio Announces First Quarter 2026 Financial Results

May 7, 2026, 4:05 PM EDT - 3 months ago

PacBio Announces First Quarter 2026 Financial Results


Pacific Biosciences of California Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Pacific Biosciences of California Proxy statement: Proxy filing


Pacific Biosciences of California Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Pacific Biosciences of California Proxy statement: Proxy filing


PacBio price target lowered to $1 from $1.50 at Barclays

2026-04-14T10:47:16.000Z - 4 months ago

PacBio price target lowered to $1 from $1.50 at Barclays


PacBio HiFi selected by Basecamp Research AI lab

2026-03-18T13:10:45.000Z - 5 months ago

PacBio HiFi selected by Basecamp Research AI lab


PacBio downgraded to Underweight from Equal Weight at Barclays

2026-03-06T11:31:43.000Z - 5 months ago

PacBio downgraded to Underweight from Equal Weight at Barclays


PacBio downgraded to Underweight from Equal Weight at Barclays

2026-03-06T11:11:00.000Z - 5 months ago

PacBio downgraded to Underweight from Equal Weight at Barclays


PacBio appoints Gibson to Board of Directors

2026-03-05T13:44:59.000Z - 5 months ago

PacBio appoints Gibson to Board of Directors

RXRX


PacBio files automatic mixed securities shelf

2026-02-25T22:11:20.000Z - 6 months ago

PacBio files automatic mixed securities shelf


Pacific Biosciences of California Annual report: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Annual report: Q4 2025


Pacific Biosciences of California Earnings release: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Earnings release: Q4 2025


Pacific Biosciences of California Slides: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Slides: Q4 2025


Pacific Biosciences of California Annual report: Q4 2025

Feb 12, 2026, 5:00 PM EST - 6 months ago

Pacific Biosciences of California Annual report: Q4 2025


PacBio reports Q4 EPS (12c), consensus (13c)

2026-02-12T21:18:04.000Z - 6 months ago

PacBio reports Q4 EPS (12c), consensus (13c)


PacBio announces collaboration with iHope

2026-02-12T12:23:09.000Z - 6 months ago

PacBio announces collaboration with iHope


PacBio completes sale of short-read sequencing assets

2026-02-02T14:11:41.000Z - 7 months ago

PacBio completes sale of short-read sequencing assets


PacBio Completes Sale of Short-Read Sequencing Assets

Feb 2, 2026, 9:05 AM EST - 7 months ago

PacBio Completes Sale of Short-Read Sequencing Assets


Pacific Biosciences of California Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pacific Biosciences of California Quarterly report: Q3 2025


Pacific Biosciences of California Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pacific Biosciences of California Earnings release: Q3 2025


Pacific Biosciences of California Slides: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pacific Biosciences of California Slides: Q3 2025


Pacific Biosciences of California Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Pacific Biosciences of California Quarterly report: Q2 2025


Pacific Biosciences of California Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Pacific Biosciences of California Earnings release: Q2 2025


Pacific Biosciences of California Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Pacific Biosciences of California Slides: Q2 2025


PacBio to Present at Upcoming Investor Conferences

Aug 6, 2025, 9:00 AM EDT - 1 year ago

PacBio to Present at Upcoming Investor Conferences


Pacific Biosciences of California Transcript: AGM 2025

Jun 4, 2025, 12:00 PM EDT - 1 year ago

Pacific Biosciences of California Transcript: AGM 2025


Pacific Biosciences of California Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pacific Biosciences of California Quarterly report: Q1 2025


Pacific Biosciences of California Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pacific Biosciences of California Earnings release: Q1 2025


Pacific Biosciences of California Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pacific Biosciences of California Slides: Q1 2025


PacBio Announces First Quarter 2025 Financial Results

May 8, 2025, 4:15 PM EDT - 1 year ago

PacBio Announces First Quarter 2025 Financial Results


PacBio Grants Equity Incentive Award to New Employee

Apr 4, 2025, 7:45 PM EDT - 1 year ago

PacBio Grants Equity Incentive Award to New Employee


Pacific Biosciences Names Jim Gibson Chief Financial Officer

Mar 27, 2025, 9:22 AM EDT - 1 year ago

Pacific Biosciences Names Jim Gibson Chief Financial Officer


Jim Gibson to join PacBio as Chief Financial Officer

Mar 27, 2025, 9:05 AM EDT - 1 year ago

Jim Gibson to join PacBio as Chief Financial Officer


dopeles
dopeles Aug. 19 at 5:26 PM
$MRNA + $PACB I’m calling it
0 · Reply
dopeles
dopeles Aug. 19 at 5:21 PM
$PACB ‼️🚨 ….Moderna will acquire PACB …bcus nothig else makes sense
0 · Reply
PraRed
PraRed Aug. 19 at 5:12 PM
$MRNA $PACB 👀🫣👀🫣✅
0 · Reply
Multi_Millions
Multi_Millions Aug. 19 at 4:13 PM
0 · Reply
FinanceCorp
FinanceCorp Aug. 19 at 3:50 PM
0 · Reply
MingLin
MingLin Aug. 19 at 3:47 PM
$PACB more meat next short reverse split land 👍🏽🇨🇳
1 · Reply
egcgfiend
egcgfiend Aug. 19 at 2:46 PM
$PACB 100x coming
1 · Reply
lilin_
lilin_ Aug. 19 at 2:43 PM
$PACB 誰在昨天買了更多
1 · Reply
severfire
severfire Aug. 19 at 2:24 PM
$MRNA Worth knowing it is good to do genetic testing during genetic curation. I guess $PACB would be best fit here!
0 · Reply
severfire
severfire Aug. 19 at 2:04 PM
$PACB from AI: DNA tests are strongly recommended and often required during genetic curations. They provide the core molecular data needed to interpret gene-disease validity, classify variant pathogenicity, and confirm clinical findings in genomic databases. Role of DNA Tests in Curations Variant Discovery: Identifies specific changes in the genetic code of affected individuals. Segregation Analysis: Tests family members to see if the DNA change tracks with the disease. Functional Correlation: Links specific genotypes to observed patient phenotypes.Database Populating: Feeds real-world genomic data into expert panels like ClinGen.
0 · Reply
severfire
severfire Aug. 19 at 2:03 PM
$PACB worth knowing that it would be recommended to do DNA tests during genetic curations!
0 · Reply
egcgfiend
egcgfiend Aug. 19 at 2:02 PM
$PACB short culos will be completely gaping and blown out soon
0 · Reply
Yooman
Yooman Aug. 19 at 1:59 PM
$PACB Target 10 in the next 6 months.
0 · Reply
egcgfiend
egcgfiend Aug. 19 at 1:40 PM
$PACB oooooooh no!!! @MingLin 's tight Chinese cuuulo!!!!
0 · Reply
severfire
severfire Aug. 19 at 1:34 PM
$PACB lets prepare for short sqeeze?
0 · Reply
egcgfiend
egcgfiend Aug. 19 at 1:22 PM
$PACB all the shorts having sphincter dyskinesia when any news about precision medicine breaks
0 · Reply
egcgfiend
egcgfiend Aug. 19 at 1:07 PM
$PACB not only will this recover, but it will end up being the backbone of precision medicine because the highest quality/most accurate genomes will be the baseline for the patient.......
1 · Reply
SSom
SSom Aug. 19 at 12:48 PM
$PACB $MRNA What if personalized oncology becomes the next major application for sequencing? MRNA’s breakthrough today could validate a much larger precision-oncology market. $PACB is trading at a tiny fraction of the valuations of many biotech names. How undervalued could PacBio be if HiFi sequencing becomes part of the personalized cancer workflow?
1 · Reply
FinanceCorp
FinanceCorp Aug. 19 at 12:43 PM
$PACB give me a run to $3, CONSOLIDATE , then come out with some good news, and then give me a run to $11
0 · Reply
severfire
severfire Aug. 19 at 9:02 AM
$PACB worth to know: https://www.pacb.com/3rd-party-compatible-products/
0 · Reply
severfire
severfire Aug. 19 at 9:01 AM
$PACB here are some data i found: BLACKROCK, INC. added 7,072,121 shares (+28.0%) in Q2 2026, for ~ $11,881,163 ARK INVESTMENT MANAGEMENT LLC removed 6,491,872 shares (-17.9%) from their portfolio in Q2 2026, for ~ $10,906,344 POINT72 ASSET MANAGEMENT, L.P. added 4,501,600 shares (+1575.6%) in Q2 2026, for ~ $7,562,688 SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,652,298 shares (+inf%) in Q2 2026, for ~ $4,455,860 GOLDMAN SACHS GROUP INC added 2,241,420 shares (+226.8%) in Q2 2026, for ~ $3,765,585
0 · Reply
DomLuminous
DomLuminous Aug. 18 at 8:21 PM
$PACB I still throw lunch money at this name in hopes it does an NVDA one day
0 · Reply